Kymera Therapeutics, Inc. · NASDAQ:KYMR

Chadwick Jeremy G sold 17,184 Kymera Therapeutics, Inc. shares (Form 4)

Traded May 26 to May 27, 2026 · Filed May 27, 2026

From May 26 to May 27, 2026, Chadwick Jeremy G (Chief Operating Officer) sold 17,184 Kymera Therapeutics, Inc. shares at an average US$79.92 for US$1.37M under a trading plan, leaving 44,018 shares. Filed May 27, 2026 (Form 4).

Sold
17,184 shares
Price
US$79.92 average (US$78.36 to US$82.08)
Value
US$1.37M
Holding after
44,018 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 26, 2026Common StockSale3,730US$78.3657,472Direct
May 26, 2026Common StockSale324US$79.1757,148Direct
May 26, 2026Common StockSale3,800US$79.3953,348Direct
May 26, 2026Common StockSale4,500US$80.0248,848Direct
May 26, 2026Common StockSale551US$80.7148,297Direct
May 27, 2026Common StockSale3,679US$81.5044,618Direct
May 27, 2026Common StockSale600US$82.0844,018Direct

Source

View original at SEC

Related